| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 临床试验技术服务(元) | 1,773,393,481.98 | 3,266,805,018.61 | 1,469,530,239.35 | 3,178,139,885.72 | 1,637,121,812.15 |
| 临床试验相关服务及实验室服务(元) | 1,842,439,422.82 | 3,446,527,556.38 | 1,709,812,407.45 | 3,295,945,213.34 | 1,658,572,481.28 |
| 营业成本(元) | |||||
| 临床试验技术服务(元) | 1,399,301,515.28 | 2,610,662,008.16 | 1,134,379,478.97 | 2,238,626,356.32 | 1,009,123,417.53 |
| 临床试验相关服务及实验室服务(元) | 1,254,163,845.12 | 2,321,691,924.51 | 1,109,930,332.91 | 2,081,675,727.87 | 997,078,285.22 |
| 毛利(元) | |||||
| 临床试验技术服务(元) | 374,091,966.70 | 656,143,010.45 | 335,150,760.38 | 939,513,529.40 | 627,998,394.62 |
| 临床试验相关服务及实验室服务(元) | 588,275,577.70 | 1,124,835,631.87 | 599,882,074.54 | 1,214,269,485.47 | 661,494,196.06 |
| 毛利率(%) | |||||
| 临床试验技术服务(%) | 21.09 | 20.09 | 22.81 | 29.56 | 38.36 |
| 临床试验相关服务及实验室服务(%) | 31.93 | 32.64 | 35.08 | 36.84 | 39.88 |
| 收入构成(%) | |||||
| 临床试验技术服务(%) | 49.05 | 48.66 | 46.22 | 49.09 | 49.67 |
| 临床试验相关服务及实验室服务(%) | 50.95 | 51.34 | 53.78 | 50.91 | 50.33 |
| 毛利构成(%) | |||||
| 临床试验技术服务(%) | 38.87 | 36.84 | 35.84 | 43.62 | 48.70 |
| 临床试验相关服务及实验室服务(%) | 61.13 | 63.16 | 64.16 | 56.38 | 51.30 |